ArticleInternational journal of molecular sciences2026
Antitumor Activity of a Synthetic Small RNA Based on a
Dengyuan Liu, Xinmeng Yang, Sifen Du, Na Sun, Yexuan Lin, Yixin Dong, Chengyu Jiang
Abstract read
In one paragraphArticle in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Dengyuan LiuState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.ORCID 0009-0004-6929-2299 Xinmeng YangState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Sifen DuState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Na SunState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.ORCID 0000-0002-8107-3732 Yexuan LinState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Yixin DongState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Chengyu JiangState Key Laboratory of Common Mechanism Research for Major Diseases, Department of Biochemistry, Institute of Basic Medical Sciences & School of Basic Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
Funding
Chinese Academy of Medical Sciences & Peking Union Medical College 2021-I2M-1-014Chinese Academy of Medical Sciences & Peking Union Medical College 2021-I2M-1-022
6 · The paper itselfAbstract
Lung cancer remains the leading cause of cancer-related mortality worldwide, highlighting the urgent need for novel therapeutic strategies. This study aimed to identify bioactive small RNAs derived from
Indexed as
Antineoplastic AgentsCarcinoma, Non-Small-Cell LungLung NeoplasmsAnimalsApoptosisCell Line, TumorCell ProliferationCell SurvivalGene Expression Regulation, NeoplasticHumansMiceProto-Oncogene Proteins p21(ras)Xenograft Model Antitumor AssaysAntineoplastic AgentsKRAS protein, humanProto-Oncogene Proteins p21(ras)KRASMaytenus hookeri Loes.non-small cell lung canceroligonucleotide therapeuticssmall RNA
Identifiers
PMID42737502
PMCPMC13566342
What OpenQuestion holds
Textmetadata
Read underepoch 390